logo
Sign in

PRCT Stock Price, Chart, Stats & News

PROCEPT BioRobotics Corporation
Save
1.19B
Market cap
Current P/E
Forward P/E

PRCT chart

1M
3M
1Y
5Y
Loading chart...

Fundamentals

Gross margin
63.70%
Operating margin
-33.71%
Pretax margin
-30.96%
Net margin
-31.02%
Effective tax rate
-0.20%
ROA
-18.81%
ROE
-25.13%
D/E
0.14x
Interest coverage ratio
-11.69x

PRCT valuation

P/E
P/S
4.83x
P/B
4.01x
P/CF
-29.99x
P/FCF
-25.48x
P/OCF
-29.99x
PEG
1.24x
EV multiple
-21.49x

About

PROCEPT BioRobotics Corporation specializes in pioneering surgical robotic technologies, offering innovative solutions within the field of urology. Its flagship product is the AquaBeam Robotic System, a sophisticated, image-guided surgical robot designed for minimally invasive urological procedures. This system primarily facilitates Aquablation therapy, which the company also devised, to alleviate lower urinary tract symptoms in male patients diagnosed with benign prostatic hyperplasia (BPH).

Similar securities

Based on sector and market capitalization

Report issue